Vol 42 - N° 2 - février 2025
P. 75-116© SPLF
Rev. Mal. Respir. February 2025; 42(2): i. Publication en ligne : 6 February 2025
PDF HTML accès libre
Antibioprophylaxis failure with BCG therapy for bladder neoplasia
N. Argoulon, H. Morel, P. Lanotte, M. Ferreira, T. Prazuck, S. Marchand-Adam
Rev. Mal. Respir. February 2025; 42(2): 75-80. Publication en ligne : 6 February 2025
Factors associated with venous thromboembolism in tuberculosis patients in Burkina Faso: A case control study
O. Dembélé, S. Maïga, A.R. Ouédraogo, A. Sourabié, D. Soubeiga, T.C. Ngo Ngue, A. Ouédraogo, M. Zongo, C. Essaga Eloundou, E. Bonsa, M.L. Ali Moussa, A. Coulibaly, E. Birba, K. Boncoungou, M. Ouédraogo
Rev. Mal. Respir. February 2025; 42(2): 81-7. Publication en ligne : 6 February 2025
Elexacaftor, Tezacaftor and Ivacaftor: immediate efficacy evaluation using home spirometry
M. Thimmesch, M. Boulay, E. Defgnée, N. Bauwens, A. Palem
Rev. Mal. Respir. February 2025; 42(2): 88-93. Publication en ligne : 6 February 2025
The repercussions of variations in ambient air pressure on pulmonary airway dystrophy. Applications to scuba diving with mask, commercial air travel and stays in high-altitude settings
D. Coëtmeur, B. Lemmens, S. Storme
Rev. Mal. Respir. February 2025; 42(2): 94-100. Publication en ligne : 6 February 2025
When tuberculosis makes you deaf
V. Cauhape, K. Risso, E. Demonchy, V. Flory, N. Guevara, F. Vandenbos
Rev. Mal. Respir. February 2025; 42(2): 101-3. Publication en ligne : 6 February 2025
Pneumonia and pregnancy
A. Shalaby, M. Lachâtre, C. Charlier
Rev. Mal. Respir. February 2025; 42(2): 104-116. Publication en ligne : 6 February 2025